Research graph
References from Neoadjuvant Hormonal Therapy Before Radical Prostatectomy: Favorable Pathological and PSA Outcomes Do Not Guarantee Favorable Oncological Outcomes. Local targets link to admitted publications; unresolved targets remain external evidence.
Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2024 · External reference
Long‐Term Data on the Survival of Patients With Prostate Cancer Treated With Radical Prostatectomy in the Prostate‐Specific Antigen Era
10.1111/j.1464-410x.2009.09134.x · 2010 · External reference
Persistent Prostate‐Specific Antigen After Radical Prostatectomy and its Impact on Oncologic Outcomes
10.1016/j.eururo.2019.01.048 · 2019 · External reference
Robot‐Assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients With Locally‐Advanced Prostate Cancer
10.1016/j.eururo.2016.05.008 · 2017 · External reference
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report From the EAU Robotic Urology Section Scientific Working Group
10.1016/j.euo.2023.11.021 · 2024 · External reference
Relative Impact of Lymph‐Node Metastasis and Seminal Vesical Invasion on Oncologic Outcomes Following Radical Prostatectomy
10.1038/s41391-023-00724-9 · 2024 · External reference
Identification of Prostate Cancer Risk Categories According to Surgical Margins Status, Pathological Stage and Gleason Score
10.1111/iju.12124 · 2013 · External reference
Prognosis of Patients With Pelvic Lymph Node (LN) Metastasis After Radical Prostatectomy: Value of Extranodal Extension and Size of the Largest LN Metastasis
10.1111/bju.12342 · 2014 · External reference
Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death
10.1200/jco.21.02800 · 2022 · External reference
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients With Positive Margins or Extracapsular Extension
10.1016/j.eururo.2019.07.001 · 2019 · External reference
Timing of Radiotherapy (Rt) After Radical Prostatectomy (RP): Long‐Term Outcomes in the RADICALS‐RT Trial (NCT00541047)
10.1016/j.annonc.2024.03.010 · 2024 · External reference
Unresolved reference
External reference
4‐Year Follow‐Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy Prior to Radical Prostatectomy in T2‐3N0M0 Prostate Cancer
10.1159/000020366 · 2000 · External reference
Neoadjuvant Hormone Treatment With Leuprolide Acetate Depot 3.75 mg and Cyproterone Acetate, Before Radical Prostatectomy: A Randomized Study
10.1159/000077113 · 2004 · External reference
Neoadjuvant Enzalutamide Prior to Prostatectomy
10.1158/1078-0432.ccr-16-1357 · 2017 · External reference
Neo‐Adjuvant and Adjuvant Hormone Therapy for Localised and Locally Advanced Prostate Cancer
2006 · External reference
Neoadjuvant Hormone Therapy for Patients With High‐Risk Prostate Cancer: A Systematic Review and Meta‐Analysis
10.4103/aja.aja_96_20 · 2021 · External reference
Disseminated Tumor Cells in Prostate Cancer Patients After Radical Prostatectomy and Without Evidence of Disease Predicts Biochemical Recurrence
10.1158/1078-0432.ccr-08-1754 · 2009 · External reference
Long‐Term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High‐Risk Prostate Cancer
10.1016/j.eururo.2025.01.015 · 2025 · External reference
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix With or Without Apalutamide Prior to Radical Prostatectomy for High‐Risk Prostate Cancer (ARNEO)
10.1016/j.euo.2025.12.005 · 2026 · External reference
Neoadjuvant Fuzuloparib Combined With Abiraterone for Localized High‐Risk Prostate Cancer (FAST‐PC): A Single‐Arm Phase 2 Study
10.1016/j.xcrm.2025.102018 · 2025 · External reference
Neoadjuvant Hormonal Therapy before Radical Prostatectomy in High‐Risk Prostate Cancer
10.1038/s41585-021-00514-9 · 2021 · External reference
Comparison of Short‐Term and Long‐Term Neoadjuvant Hormone Therapy Prior to Radical Prostatectomy: A Systematic Review and Meta‐Analysis
10.1080/21681805.2022.2034941 · 2022 · External reference
Randomized Comparative Study of 3 Versus 8‐month Neoadjuvant Hormonal Therapy before Radical Prostatectomy: Biochemical and Pathological Effects
10.1016/s0022-5347(05)65971-x · 2001 · External reference
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix With or Without Apalutamide Prior to Radical Prostatectomy for High‐Risk Prostate Cancer
10.1016/j.eururo.2022.09.009 · 2023 · External reference
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy Prior to Radical Prostatectomy in Men With High‐Risk Localized Prostate Cancer
10.1097/ju.0000000000001702 · 2021 · External reference
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
10.1200/jco.18.01777 · 2019 · External reference
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High‐Risk Prostate Cancer
10.1200/jco.20.00315 · 2020 · External reference
Perioperative Apalutamide in High‐Risk Localized Prostate Cancer
10.1056/nejmoa2603878 · 2026 · External reference
Clinical and Biological Characterisation of Localised High‐Risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone‐Releasing Hormone Agonist With or Without Abiraterone Acetate Plus Prednisone
10.1016/j.eururo.2019.05.010 · 2019 · External reference
The Association Between [(68)Ga]PSMA PET/CT Response and Biochemical Progression in Patients With High‐Risk Prostate Cancer Receiving Neoadjuvant Therapy
10.2967/jnumed.122.265368 · 2023 · External reference
Timing of Radiotherapy (Rt) After Radical Prostatectomy (RP): Long‐Term Outcomes in the RADICALS‐RT Trial (NCT00541047)
10.1016/j.annonc.2024.03.010 · ExternalCitation · doi-reference
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report From the EAU Robotic Urology Section Scientific Working Group
10.1016/j.euo.2023.11.021 · ExternalCitation · doi-reference
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix With or Without Apalutamide Prior to Radical Prostatectomy for High‐Risk Prostate Cancer (ARNEO)
10.1016/j.euo.2025.12.005 · ExternalCitation · doi-reference
Robot‐Assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients With Locally‐Advanced Prostate Cancer
10.1016/j.eururo.2016.05.008 · ExternalCitation · doi-reference
Persistent Prostate‐Specific Antigen After Radical Prostatectomy and its Impact on Oncologic Outcomes
10.1016/j.eururo.2019.01.048 · ExternalCitation · doi-reference
Clinical and Biological Characterisation of Localised High‐Risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone‐Releasing Hormone Agonist With or Without Abiraterone Acetate Plus Prednisone
10.1016/j.eururo.2019.05.010 · ExternalCitation · doi-reference
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients With Positive Margins or Extracapsular Extension
10.1016/j.eururo.2019.07.001 · ExternalCitation · doi-reference
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix With or Without Apalutamide Prior to Radical Prostatectomy for High‐Risk Prostate Cancer
10.1016/j.eururo.2022.09.009 · ExternalCitation · doi-reference
Long‐Term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High‐Risk Prostate Cancer
10.1016/j.eururo.2025.01.015 · ExternalCitation · doi-reference
Neoadjuvant Fuzuloparib Combined With Abiraterone for Localized High‐Risk Prostate Cancer (FAST‐PC): A Single‐Arm Phase 2 Study
10.1016/j.xcrm.2025.102018 · ExternalCitation · doi-reference
Randomized Comparative Study of 3 Versus 8‐month Neoadjuvant Hormonal Therapy before Radical Prostatectomy: Biochemical and Pathological Effects
10.1016/s0022-5347(05)65971-x · ExternalCitation · doi-reference
Relative Impact of Lymph‐Node Metastasis and Seminal Vesical Invasion on Oncologic Outcomes Following Radical Prostatectomy
10.1038/s41391-023-00724-9 · ExternalCitation · doi-reference
Neoadjuvant Hormonal Therapy before Radical Prostatectomy in High‐Risk Prostate Cancer
10.1038/s41585-021-00514-9 · ExternalCitation · doi-reference
Perioperative Apalutamide in High‐Risk Localized Prostate Cancer
10.1056/nejmoa2603878 · ExternalCitation · doi-reference
Comparison of Short‐Term and Long‐Term Neoadjuvant Hormone Therapy Prior to Radical Prostatectomy: A Systematic Review and Meta‐Analysis
10.1080/21681805.2022.2034941 · ExternalCitation · doi-reference
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy Prior to Radical Prostatectomy in Men With High‐Risk Localized Prostate Cancer
10.1097/ju.0000000000001702 · ExternalCitation · doi-reference
Prognosis of Patients With Pelvic Lymph Node (LN) Metastasis After Radical Prostatectomy: Value of Extranodal Extension and Size of the Largest LN Metastasis
10.1111/bju.12342 · ExternalCitation · doi-reference
Identification of Prostate Cancer Risk Categories According to Surgical Margins Status, Pathological Stage and Gleason Score
10.1111/iju.12124 · ExternalCitation · doi-reference
Long‐Term Data on the Survival of Patients With Prostate Cancer Treated With Radical Prostatectomy in the Prostate‐Specific Antigen Era
10.1111/j.1464-410x.2009.09134.x · ExternalCitation · doi-reference
Disseminated Tumor Cells in Prostate Cancer Patients After Radical Prostatectomy and Without Evidence of Disease Predicts Biochemical Recurrence
10.1158/1078-0432.ccr-08-1754 · ExternalCitation · doi-reference
Neoadjuvant Enzalutamide Prior to Prostatectomy
10.1158/1078-0432.ccr-16-1357 · ExternalCitation · doi-reference
4‐Year Follow‐Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy Prior to Radical Prostatectomy in T2‐3N0M0 Prostate Cancer
10.1159/000020366 · ExternalCitation · doi-reference
Neoadjuvant Hormone Treatment With Leuprolide Acetate Depot 3.75 mg and Cyproterone Acetate, Before Radical Prostatectomy: A Randomized Study
10.1159/000077113 · ExternalCitation · doi-reference
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
10.1200/jco.18.01777 · ExternalCitation · doi-reference
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High‐Risk Prostate Cancer
10.1200/jco.20.00315 · ExternalCitation · doi-reference
Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death
10.1200/jco.21.02800 · ExternalCitation · doi-reference
The Association Between [(68)Ga]PSMA PET/CT Response and Biochemical Progression in Patients With High‐Risk Prostate Cancer Receiving Neoadjuvant Therapy
10.2967/jnumed.122.265368 · ExternalCitation · doi-reference
Neoadjuvant Hormone Therapy for Patients With High‐Risk Prostate Cancer: A Systematic Review and Meta‐Analysis
10.4103/aja.aja_96_20 · ExternalCitation · doi-reference
